NYSE:MO 6 April 2026

BAT shares extend rally as FDA shift gives Vuse and Velo a cleaner U.S. read

BAT shares extend rally as FDA shift gives Vuse and Velo a cleaner U.S. read

British American Tobacco moved higher in London Wednesday, building on a strong surge that set it apart during Tuesday’s sluggish trading. Shares traded at GBX 4,713.78 according to Google Finance, a 1.72% gain and close to the upper end of the morning’s moves—just shy of the 52-week peak at GBX 4,876.92. Investors reacted after U.S. regulators offered more clarity. The FDA’s latest enforcement guidance signals it won’t be targeting some e-cigarette and oral nicotine pouch products that haven’t secured final authorization yet, as long as their premarket applications are still pending. Those applications—required before companies can legally introduce new tobacco products—remain under review.
May 13, 2026
British American Tobacco Shares Edge Up as Buyback Runs, but Velo FDA Delay Clouds 2026

British American Tobacco Shares Edge Up as Buyback Runs, but Velo FDA Delay Clouds 2026

British American Tobacco p.l.c.’s U.S. shares ticked up 0.2% in New York on Monday. Investors are still waiting to see when U.S. regulators will give the green light to Velo nicotine pouches—a key question ahead of the group’s April 15 annual meeting. BAT is pressing on with its £1.3 billion share buyback, announced for 2026. BAT’s push into smoke-free—vapes, heated tobacco, oral nicotine—comes as cigarette volumes slip. Back in February, the company said these alternatives accounted for 18.2% of 2025 sales, sticking with 2026 guidance, though only at the bottom of its targeted range.
April 6, 2026